US Stocks
/
Oramed Pharmaceuticals Inc. Share Price

Oramed Pharmaceuticals Inc. Share Price

NASDAQ: ORMP | Micro Cap
$4.30
-$0.02 (-0.46%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Oramed Pharmaceuticals Inc. Stock Performance

Open
$4.37
Prev. Close
$4.32
Circuit Range
N/A
Day Range
$4.29 - $4.37
Year Range
$2.06 - $5.16
Volume
3,990
Average Traded
$4.32

Oramed Pharmaceuticals Inc. Share Price Today

As of 10 August 2026, Oramed Pharmaceuticals Inc.'s share price is $4.30. The stock opened at $4.37, compared to its previous close of $4.32. During today's trading session, Oramed Pharmaceuticals Inc.'s share price traded between $4.29 and $4.37, with an average price of $4.33. Over the past 52 weeks, the stock has recorded a high of $5.16 and a low of $2.06. In terms of performance, Oramed Pharmaceuticals Inc.'s share price has risen by 26.10% over the last six months and is up 97.25% on a year-on-year basis.

Oramed Pharmaceuticals Inc. Share Price Chart

$4.29$4.37
L
Show Current Price
H

Oramed Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Market Cap
$178.03M
PE Ratio (TTM)
2.81
Dividend Yield
N/A
EPS (TTM)
$1.53
Revenue (TTM)
$2.00M
Return On Equity (TTM)
32.05%
Profit Margin
3200.80%
Debt to Equity
0.10
Quarterly Earnings Growth YoY
N/A

Oramed Pharmaceuticals Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2025
Revenue$2.00M
Net Profit-$7.64M
Net Profit Margin-382.10%
Income ChangeN/A

Oramed Pharmaceuticals Inc. Annual Profit & Loss

All figures in USD

Particulars202220232025
Revenue$2.70M$1.34M$2.00M
Net Profit-$37.76M$5.09M$64.05M
Net Profit Margin-1397.11%379.70%3202.50%
Income ChangeN/A113.47%1158.84%

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Oramed Pharmaceuticals Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$4.15
$4.30
+5.52%
Jul 2026
$4.67
$4.08
-15.10%
Jun 2026
$3.98
$4.80
+20.30%
May 2026
$3.93
$3.99
+2.31%
Apr 2026
$3.42
$3.90
+14.04%
Mar 2026
$3.44
$3.42
+0.29%
Feb 2026
$3.29
$3.41
+1.19%
Jan 2026
$2.86
$3.37
+18.25%
Dec 2025
$2.76
$2.85
-0.35%
Nov 2025
$2.37
$2.86
+20.42%
Oct 2025
$2.61
$2.38
-9.70%
Sep 2025
$2.18
$2.63
+20.64%

ORMP Share Price FAQs

What is Oramed Pharmaceuticals Inc. share price today?

chevron-up
Oramed Pharmaceuticals Inc. share price today is $4.30 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Oramed Pharmaceuticals Inc. stock?

chevron-up
The 52 week high of Oramed Pharmaceuticals Inc. stock is $5.16, while the 52 week low is $2.06 as of 8 Aug '26.

What is ORMP's market capitalisation today?

chevron-up
ORMP market capitalisation is $178.03M as of August 10, 2026, at 1:33 pm IST.

What is ORMP's net income for the last quarter?

chevron-up
ORMP's net income for the last quarter is -0.01B USD.

What is the 5 year returns of ORMP?

chevron-up
The 5 year returns of ORMP is -78.15% as on 8 Aug '26.

What is the high & low stock price of ORMP today?

chevron-up
ORMP stock price hit a high of $4.37 and low of $4.29 as of 8 Aug '26.

Can I buy ORMP shares in India?

chevron-up
Yes. You can buy ORMP in India by opening an international trading account.